-
Table of Contents
Patents and Formulations History of Turinabol
Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was first developed in the 1960s by the East German pharmaceutical company, Jenapharm. It was initially used for medical purposes, such as treating muscle wasting diseases and osteoporosis, but it quickly gained popularity among athletes for its performance-enhancing effects. In this article, we will delve into the patents and formulations history of turinabol, exploring its development, uses, and controversies.
Development of Turinabol
The development of turinabol can be traced back to the 1950s when scientists were looking for a way to create a more potent version of testosterone. The goal was to create a steroid that would have strong anabolic effects while minimizing androgenic side effects. This led to the creation of 4-chlorotestosterone, which was later modified to become 4-chlorodehydromethyltestosterone, or turinabol.
The first patent for turinabol was filed in 1961 by Jenapharm, and it was approved for medical use in 1965. It was primarily used to improve the physical performance of athletes, especially those in the East German Olympic team. The East German government heavily funded the development and production of turinabol, and it was widely used by their athletes in the 1970s and 1980s.
Formulations of Turinabol
Turinabol was initially available in oral form, with a recommended dosage of 5-10mg per day for medical purposes. However, for performance enhancement, athletes would often take much higher doses, ranging from 20-50mg per day. This led to an increase in the risk of side effects, which we will discuss later in this article.
In the 1970s, Jenapharm also developed an injectable form of turinabol, which was marketed as Turinabol Depot. This formulation was designed to have a longer half-life, allowing for less frequent injections. However, it was not as popular as the oral form, and it was eventually discontinued.
Over the years, there have been various formulations of turinabol, including different esters and prodrugs. However, the most commonly used form is still the oral tablets, which are widely available on the black market.
Uses of Turinabol
Turinabol was primarily used for performance enhancement in the world of sports. It was believed to increase muscle mass, strength, and endurance, without causing excessive water retention or bloating. This made it a popular choice among athletes in sports that require speed and power, such as sprinting, weightlifting, and boxing.
Aside from its performance-enhancing effects, turinabol was also used for medical purposes. It was prescribed to patients with muscle wasting diseases, such as HIV/AIDS, and to treat osteoporosis in postmenopausal women. However, due to the potential for abuse and misuse, its medical use has been discontinued in most countries.
Controversies Surrounding Turinabol
Despite its popularity among athletes, turinabol has been at the center of several controversies. In the 1970s and 1980s, it was widely used by the East German Olympic team, leading to accusations of state-sponsored doping. This was confirmed in 1991 when documents were released, revealing the extent of the East German government’s involvement in the doping program.
Furthermore, turinabol has been linked to several adverse effects, including liver damage, cardiovascular issues, and hormonal imbalances. In 2016, the World Anti-Doping Agency (WADA) added turinabol to its list of banned substances, citing its potential for abuse and performance enhancement.
Pharmacokinetics and Pharmacodynamics of Turinabol
As with all AAS, the pharmacokinetics and pharmacodynamics of turinabol are complex and depend on various factors, such as dosage, formulation, and individual characteristics. However, some general information can be gleaned from studies and anecdotal evidence.
Turinabol has a half-life of approximately 16 hours, meaning it takes around 16 hours for half of the drug to be eliminated from the body. This makes it a relatively long-acting steroid compared to others, such as testosterone, which has a half-life of around 4-5 hours.
When taken orally, turinabol is rapidly absorbed into the bloodstream and reaches peak levels within 1-2 hours. It is then metabolized by the liver and excreted through the urine. The exact mechanisms of action of turinabol are not fully understood, but it is believed to bind to androgen receptors in muscle tissue, promoting protein synthesis and muscle growth.
Expert Opinion
Despite its controversial history and potential for adverse effects, turinabol remains a popular choice among athletes looking to enhance their performance. However, it is important to note that the use of AAS, including turinabol, is illegal in most countries and can have serious consequences for both athletes and non-athletes.
As researchers and experts in the field of sports pharmacology, it is our responsibility to educate the public about the risks and benefits of these substances. While turinabol may have some potential benefits for medical use, its use for performance enhancement should be discouraged due to the potential for abuse and harm.
References
1. Johnson, A. C., & Bowers, L. D. (2021). Anabolic androgenic steroids. In StatPearls [Internet]. StatPearls Publishing.
2. Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.
3. Yesalis, C. E., & Bahrke, M. S. (2000). Anabolic-androgenic steroids: current issues. Sports Medicine, 29(6), 38-57.
4. World Anti-Doping Agency. (2021). The 2021 Prohibited List. Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-in-competition/anabolic-androgenic-steroids
5. Yesalis, C. E., & Bahrke, M. S. (2000). Anabolic-androgenic steroids: current issues. Sports Medicine, 29(6), 38-57.
6. Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.
7. Johnson, A. C., & B